India covid-19 patient India

Bajaj Healthcare launches 'Ivejaj' tablets for Covid treatment

Reading now: 975
www.livemint.com

Bajaj Healthcare Limited, a manufacturer of APIs, Intermediates and Formulations, has announced the launch of “Ivejaj" (Ivermectin) an AntiParasitic Drug used in control & treatment for Covid-19 patients.The company in an exchange filing said that it has received approval from India's drug regulator, to manufacture and market “Ivejaj" the oral Ivermectin approved medication in India for the treatment of Covid-19 from 6th May 2021.Bajaj Healthcare has developed the active pharmaceutical ingredient (API) and the formulation for Ivermectin through its own in-house R&D team.

Read more on livemint.com
The website covid-19.rehab is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.

Related News

DMCA